Why do some people sneeze in bright sunlight? The photic sneeze reflex
About a quarter of people sneeze on stepping into bright light. It runs in families, has been tied to specific gene variants, and looks like visual signals spilling into the sneeze circuit.
Some people sneeze, reliably, the moment they step from shade into bright sunlight — a quirk called the photic sneeze reflex that affects roughly a quarter of the population [s2]. It is an inherited wiring trait in which a strong visual signal appears to spill over into the brain's sneeze circuitry; it is harmless, has an identified genetic signature, and — despite being described for centuries — still lacks a fully proven mechanism [s1][s2][s3].
What it is
The photic sneeze reflex is an involuntary sneeze, or run of sneezes, triggered by sudden bright-light exposure. A 2025 review in Experimental Brain Research puts its prevalence at approximately 25% of people and notes that, despite a long history in the scientific literature, the underlying mechanism remains unclear [s2]. It is sometimes given the backronym ACHOO, for autosomal-dominant compelling helio-ophthalmic outburst — a nod to the fact that it clearly runs in families.
The genetics came first
The strongest independent evidence that this is a heritable trait, rather than a habit, came from a 2010 study in PLoS Genetics [s1]. Using a web-based, self-reporting research design across a large participant cohort, the team screened 22 traits and validated the approach by re-discovering known genes for hair, eye colour and freckling [s1]. Among the novel findings, photic sneezing was associated with two genetic variants — rs10427255, near the gene ZEB2, and rs11856995, near NR2F2 [s1]. The association does not by itself explain the wiring, but it anchors the reflex in inherited biology and gives later work specific molecular leads to chase.
How a sneeze is built, and where light gets in
To see why light might trigger a sneeze, it helps to know how an ordinary sneeze is assembled. A 2026 review in Acta Neurologica Belgica describes the sneeze as a two-stage protective reflex — an initial sensory phase and an efferent respiratory phase — orchestrated by the ventromedial spinal trigeminal nucleus in the brainstem [s3]. The trigger normally travels along small-diameter, Trpv1-positive nasal sensory neurons that release the signalling molecule neuromedin B [s3]. That the trigeminal system sits at the centre is the key clue: the same nerve, the trigeminal, also carries sensation from the eyes and face. How central that brainstem hub is shows up in its failures — the same review notes that lateral medullary syndrome, a stroke of the brainstem, can abolish the ability to sneeze even when the urge is preserved [s3].
The leading explanation for the photic reflex is therefore a kind of crossed wire. The Acta Neurologica Belgica review characterises photic sneezing as a visual-somatosensory cross-activation — a bright visual signal bleeding into the trigeminal sneeze pathway [s3]. The Experimental Brain Research review lays out the competing versions of that idea: optic-trigeminal summation, parasympathetic hypersensitivity, and parasympathetic generalisation, none of which has yet been conclusively validated [s2].
Why it is still unsettled
For a trait this common, the science is surprisingly thin. The 2025 review searched the literature and, from 167 records screened, found only seven studies that examined the light conditions triggering the reflex — four of them single case reports and three small laboratory experiments [s2]. No study, the authors note, has yet mapped the parametric relationship between light properties and the sneeze, and reliably reproducing the reflex in a laboratory has proved hard [s2]. That is the honest state of things: the reflex is real, common and heritable, its genetic footprint is known, and its most likely mechanism is a crosstalk between visual and trigeminal signals — but the precise circuit has not been pinned down.
The same circuitry, when it becomes hyperactive rather than cross-wired, drives the far more familiar problem of allergic sneezing: the Acta Neurologica Belgica review describes pathological, repetitive sneezing in allergic rhinitis and chronic rhinosinusitis as the product of neuroimmune cross-talk along those same trigeminal sensory neurons [s3]. Photic sneezing and a bout of hay fever, in other words, share a final common pathway — one triggered by light, the other by allergen.
The gap in the photic story is not merely academic. Understanding the reflex bears on settings where an unexpected sneeze is inconvenient or worse, and the reviews argue that controlled experiments are needed to move from a plausible story to a proven pathway [s2][s3]. For now, if you sneeze walking out of a cinema into the afternoon sun, you are experiencing one of the better-documented and least-understood reflexes in human biology. This article is informational and not medical advice.
For related coverage of everyday biology that turns out to be more specific than the folklore, see how stress and hair greying trace to defined nerve pathways, and what the evidence shows for treating the allergic version of runaway sneezing in allergen immunotherapy.
Sources
- Web-based, participant-driven studies yield novel genetic associations for common traits — PLoS Genetics, 2010-06-24
- Stimulus conditions eliciting sneezing in response to bright light — Experimental Brain Research, 2025-02-01
- The sneezing reflex: neurophysiology, neuroimmune pathways and clinical disorders — Acta Neurologica Belgica, 2026-08-05
Sources
- Web-based, participant-driven studies yield novel genetic associations for common traits — PLoS Genetics , June 24, 2010
- Stimulus conditions eliciting sneezing in response to bright light — Experimental Brain Research , February 1, 2025
- The sneezing reflex: neurophysiology, neuroimmune pathways and clinical disorders — Acta Neurologica Belgica , August 5, 2026
Clot-buster fails to restore vision after central retinal artery occlusion
In the phase 3 TenCRAOS trial, intravenous tenecteplase given within 4.5 hours did no better than aspirin at recovering sight, and carried more bleeding — including one fatal brain haemorrhage.
A tau-targeting Alzheimer's drug failed to slow decline in a phase 2 trial
Ceperognastat, an oral OGA inhibitor, showed no benefit on the primary cognitive endpoint at 100 weeks. The higher dose progressed 32% faster than placebo and had more serious adverse events.
An old blood-pressure drug slowed a fatal childhood brain disease
In a single-arm trial, children with vanishing white matter given guanabenz kept walking longer than matched historical controls. The design was uncontrolled and hallucinations were common early on.
Opening a narrowed but symptom-free carotid artery did not improve thinking
In the CREST-2 trials, stenting or surgery added to intensive medical treatment left cognition no better at four years than medical treatment alone in people with severe asymptomatic carotid stenosis.